Tn5 transposase (Tnp) binds to Tn5 and IS50 end inverted repeats, the outside end (OE) and the inside end (IE), to initiate transposition. We report the isolation of four Tnp mutants (YH41, TP47, EK54 and EV54) that increase the OE-mediated transposition frequency and enhance the binding af®nity of Tnp for OE DNA. In addition, two of the Tnp mutants (TP47 and EK54) appear to be change-of-speci®city mutants, since they alter the recognition of OE versus IE relative to the wild-type Tnp. EK54 enhances OE recognition but decreases IE recognition. TP47 enhances both OE and IE recognition but with a much greater enhancement for IE than for OE. This change-of-speci®city effect of TP47 is observed only when TP47 Tnp is synthesized in cis to the DNA that contains the ends. We propose that Lys54 makes a favorable interaction with an OE-speci®c nucleotide pair(s), while Pro47 may cause a more favorable interaction with an IE-speci®c nucleotide pair(s) than it does with the corresponding OE-speci®c nucleotide pair(s). A model to explain the preference of TP47 Tnp for the IE in cis but not in trans is proposed.
Introduction
Transposition is an illegitimate recombination process mediated by transposable elements such as bacterial transposons. Transposition can give rise to a variety of genome rearrangements such as insertions, deletions, inversions and chromosome fusions. The fundamental macromolecules involved in transposition are an element-encoded protein called transposase (Tnp) that catalyzes the multiple sequential steps in transposition and the speci®c DNA sequences that de®ne the ends of the element. Because of the importance and complexity of this process, it is of interest to understand the structure/function aspects of Tnp, including how it recognizes the speci®c end DNA sequences. Since transposition has a destabilizing effect on the genome, it is to be expected that many transposable elements would have evolved various strategies to minimize its frequency. A variety of mechanisms have been discovered that decrease the transposition frequency for various elements. In some cases the Tnp is synthesized infrequently (Tn10, Kleckner, 1990) , in others the Tnp is unstable (IS903, Derbyshire et al., 1990) or its activity is downregulated by some other macromolecule (Tn5, Reznikoff, 1993) . One intriguing mechanism for decreasing the frequency of transposition is for the Tnp to have evolved with suboptimal properties such as being ineffective at recognizing the speci®c end sequences that de®ne the transposable element.
Tn5 is a composite prokaryotic transposon consisting of two IS50 insertion sequences in opposite orientation¯anking a central unique region encoding three antibiotic resistances ( Figure 1(a) ; for a review of Tn5, see Reznikoff, 1993) . IS50R (Right) is itself an autonomous transposable element encoding two proteins: a 476 amino acid residue transposase protein (Tnp) that is required for transposition, and an inhibitor protein (Inh) that is translated from the same open reading frame as Tnp but lacks the N-terminal 55 amino acid residues of Tnp. Inh inhibits transposition ef®ciently both in cis and in trans (Johnson et al., 1982) ; Tnp, however, activates transposition much more ef®-ciently in cis than in trans. When it is produced in trans to another Tn5 element that also encodes its own Tnp, Tnp acts primarily to inhibit transposition of that element (Delong & Syvanen, 1991; Wiegand & Reznikoff, 1992) .
Non-productive premature multimerization is thought to be at least one of the causes of the cis preference of Tnp in activating transposition (Weinreich et al., 1994) . Other possible reasons for preferential cis activity of a protein include but are not limited to: physical and/or conformational instability of the active form of the protein (e.g. Tn903 Tnp, Derbyshire et al., 1990) ; tight, nonspeci®c DNA binding, which favors its association to the nearest DNA molecule (e.g. l Q protein, Echols et al., 1976; Burt & Brammar, 1982) ; or a temporal coupling of the translation of the protein to its function (e.g. the C terminus of the protein, when fully translated, might interfere with the DNA-binding function of the N terminus: Tn10 Tnp, Jain & Kleckner, 1993) .
Transposition of Tn5 and IS50 requires the two 19 bp DNA sequences located at the ends of the respective transposable element: two outside ends (OE) for Tn5, and one OE and one inside end (IE) for IS50 (Figure 1(a) : Johnson & Reznikoff, 1983; Sasakawa et al., 1983) . OE and IE contain 12 identical and seven non-identical base-pairs (see Figure 1 (b)). Transposition of Tn5 derivatives with different OE and IE combinations occur at different frequencies, implying that OE and IE are utilized with different ef®ciencies (Sasakawa et al., 1983; Makris et al., 1988) , and possibly form protein-DNA complexes of somewhat different components, since OE and IE overlap with different host protein recognition sites. DnaA protein stimulates Tn5 transposition through direct contact with a DnaA box located at positions 8 to 16 of OE (Yin & Reznikoff, 1987; Fuller et al., 1984; A. Bhasin, unpublished results) . IE contains two dam methylation sites, and dam methylation inhibits IEmediated transposition (Yin et al., 1988) . In wildtype (wt) Tn5, IE partially overlaps with a Fis binding consensus, which was shown in vitro to be bound by Fis protein in footprinting and gel retardation assays (Weinreich & Reznikoff, 1992) .
Generally, the ®rst step of transposition involves Tnp binding to the ends of the transposable element. Tn5 Tnp binds to OE and IE sequences in vitro (de la Cruz et al., 1993; Jilk et al., 1996) . The role of speci®c base-pairs of the end sequences in transposition and in Tnp binding in particular has been studied through genetic analyses (Makris et al., 1988; Dodson & Berg, 1989; Tomcsanyi & Berg, 1989; Jilk et al., 1993) and chemical modi®-cation/inhibition analyses (Jilk et al., 1996) . However, the role of different Tnp residues in end sequence recognition has not been studied extensively. Interestingly, Inh, which lacks only the Nterminal 55 amino acid residues of Tnp, does not bind to OE in vitro (de la Cruz et al., 1993; Weinreich et al., 1994) . This indicates that the N terminus of Tnp is important for binding to OE (and possibly IE). Through deletion analysis of Tn5 Tnp, Weinreich et al. (1993) found that deletion of 11 amino acid residues from the N terminus completely abolishes Tnp binding to OE, while deletion of three residues from the N terminus does not affect this binding. Both deletion derivatives still retain, at least partially, the normal folded conformation of wt Tnp, since they both possess a trans-inhibitory activity similar to wt Tnp. This suggests that the impaired OE binding seen with Á11 Tnp is due to a defect in the DNA-binding domain, rather than to a gross misfolding of the mutant Tnp protein. These authors also found that point mutations AT20, DN24, RH30 and AV36, and an internal six residue deletion Á30-35 all result in signi®cantly reduced or undetectable OE binding activity. All this evidence is consistent with the N terminus of Tnp being important for DNA binding.
Here, we set out to characterize which residues of Tnp are involved in binding DNA, and how binding speci®city is determined. While structural studies of Tnp and Inh are being carried out by other members of our group, we decided to take a combined genetic and biochemical approach to study the Tnp DNA-binding domain. Such an approach had been used successfully to study CAP, Lac repressor and Trp repressor-DNA interactions (for a review, see Ebright, 1991) . In order to perform this study, we assumed that Tnp activity might be limited by a low binding af®nity for the OE and IE, and that we could identify residues in the DNA-binding domain by isolating mutations with an enhanced transposition phenotype. Second, we utilized the unique feature of Tnp, that it recognizes and binds to two somewhat different sequences, OE and IE. We reasoned that a mutant that manifests an increased af®nity for the OE sequence might do so by virtue of an additional interaction with a nucleotide pair(s) that differs between the OE and IE and thus might manifest a change of OE/IE speci®city. We began by randomly mutagenizing the N-terminal one-third of Tnp (since the N-terminal part of Tnp most likely contains the DNA-binding domain, see above), and screening for mutants causing an increased or decreased transposition frequency of a Tn5-like Tn5 Transposase DNA Binding Mutants construct de®ned by two OE sequences. Among the mutants causing an increased transposition frequency (which may be due to a new speci®city for OE), we then asked if any changed the differentiation of OE versus IE recognition displayed by wt Tnp. We found two mutants that appeared to meet these requirements: EK54 and TP47. After we characterized their OE versus IE preferences in transposition in vivo, we studied their in vitro DNA-binding properties with gel shift assays. The results indicate that both Tnp mutants have an altered interaction with DNA.
Results

Isolation of Tnp N-terminal mutants
Tnp catalyzes Tn5 and IS50 transposition. The ®rst step in this process is Tnp binding to the OE and/or IE DNA. Inh is not required for transposition (it inhibits transposition in vivo), and it does not bind to OE in vitro. Since Tnp differs from Inh only at its N terminus, it is likely that the N terminus of Tnp is important for the OE/IE binding reaction. Consistent with this, several single amino acid substitutions as well as short deletions of the N terminus of Tnp have been found to result in signi®cantly reduced or undetectable OE binding activity . To investigate the possible DNA-binding function of the Tnp N-terminal region, we conducted a PCR random mutagenesis of the ®rst 166 amino acid residues using Taq DNA polymerase, as described in Materials and Methods. The population of mutagenized plasmid pRZ5412 ( Figure 2 and Table 1), encoding the MA56 Tnp (and not encoding Inh, see Materials and Methods), was electroporated into strain MW320, which contains the papillation factor pOXGen386 and see Materials and Methods) . The papillation frequency in this strain provides an estimate of the relative trans-activated OE/OE-de®ned transposition frequency caused by the newly introduced tnp gene. The resulting colonies were screened for papillation levels and compared to that of the unmutagenized pRZ5412. We screened about 1000 colonies resulting from each of nine independent PCR reactions. Overall, about 30% of the colonies demonstrated a decrease in papillation (hypopapillation), whereas only six mutants showed an increase in papillation (hyperpapillation). The six mutants with a hyperpapillation phenotype and 20 mutants with a hypopapillation phenotype were isolated, and their plasmid DNA puri®ed and sequenced. The mutants that resulted in hypopapillation phenotype are listed by Zhou (1997) . Of the 26 mutants isolated, 11 had a single point mutation, and 15 had two or more point mutations. The PCR conditions suggested by Zhou et al. (1991) , which uses low dNTP concentrations (50 mM each) and no manganese, yielded fewer double and multiple mutations and more single mutations in our hands than the PCR conditions using standard dNTP concentrations (200 mM each) and 250 mM MnCl 2 .
We were particularly interested in the six mutants that resulted in hyperpapillation, since they are more likely to directly change OE recognition than down mutants, which could simply be due to loss of function. Because some of them contained double mutations, we subcloned each point mutation, then tested the papillation phenotype of each point mutant. We found ®ve point mutations that resulted in hyperpapillation: YH41, TP47, EK54, EV54 and EK110. EK110 was isolated and studied previously, and was found not to increase DNA-binding activity (Wiegand & Reznikoff, 1992 . It was not further studied here. Both YH41 and EK54 were isolated twice in this study, and EK54 and EV54 are mutations of the same position, indicating that the possible kinds of mutations in the region mutagenized that will result in hyperpapillation under the conditions used is not much more than what has been isolated so far.
In vivo OE/IE preferences of Tnp mutants
In order to determine quantitatively if any of the four hyperpapillating tnp mutations (YH41, TP47, EK54 and EV54) changed the differential recognition of OE versus IE displayed by wt Tnp in vivo, we utilized a mating-out assay in which the frequency of transposition onto an F factor was determined (see Materials and Methods). We tested transposition frequencies of wt and mutant Tnp with different end sequence combinations (OE/OE, OE/IE or IE/IE). Since the transposition frequency mediated by wt Tnp is known to be much higher when Tnp is produced by the same DNA molecule (in cis) than when it is produced by a different molecule (in trans) as the one on which the end sequences are located (Johnson et al., 1982; Isberg et al., 1982) , we carried out the mating-out assays both in cis and in trans. The results are shown in Table 2 . All the assays in this Table were per- Figure 2 . Structure of three plasmids used in this study. The MA56 mutation is present in all of these constructs. When representing OE or IE, the arrow points towards the outside of the transposable element (from base-pair 19 to base-pair 1). The BspHI sites in pFMA187 indicate where the deletions were subsequently made to generate pRZ5452, pRZ5453 and pRZ5454, resulting in the complete loss of the tnp gene. kan, Kanamycin; amp, ampicillin; cam, chloramphenicol.
formed in a dam strain, since transposition involving the IE is known to be inhibited by dam methylation (Yin et al., 1988; unpublished All four tnp mutants increased the OE/OE transposition frequency, as expected from the screening strategy. YH41 and EV54 appeared to promote a general increase in transposition, since they increased the transposition frequency with all end combinations. These mutations may (a) interact more favorably with the DNA, either by creating a more favorable interaction with a speci®c nucleotide identical in OE and IE, or by introducing a more positive charge in the DNA binding motif so that it can better interact with the negatively charged DNA phosphate backbone, (b) interact more favorably with a host factor involved in both OE and IE transposition complexes, or (c) alter some other step in transposition. Model (a), DNA contact enhancement, is supported by our in vitro DNA-binding results reported below.
On the other hand, EK54 Tnp was found to differentiate OE versus IE more strongly, compared to wt Tnp. When OE/OE was used, EK54 increased transposition eight-to ninefold over wt T7 promoter driven overexpression plasmid for TnpÁ369 a Transposition frequencies were measured by mating-out assays. Wild-type or mutant Tnp was supplied in cis or in trans to a DNA containing the indicated end combinations. Each frequency is the average of the results obtained from ®ve independent initial transformants. Each error is the standard error of the mean, which is calculated as the sample standard deviation divided by the squareroot of 5.
b Relative frequencies are calculated by taking the wild-type transposition frequency in each group as 1. The errors in the relative frequencies are calculated by taking the errors in the corresponding absolute frequencies divided by the absolute frequency of wildtype Tnp in that group.
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Tnp; but when OE/IE, or IE/IE was used, EK54 decreased transposition four-to sixfold relative to wt Tnp (Table 2) . EK54 is thus a change-of-speci®city mutant, because it displayed an altered OE versus IE differentiation phenotype compared to wt Tnp. These results suggest that either (a) Lys54 is able to make a more favorable interaction with one or more OE speci®c base(s), or with the OE DNA backbone, compared to Glu54, or (b) EK54 Tnp interacts more favorably with an OE speci®c host factor (e.g. DnaA protein?) during transposition, than wt Tnp. Again, our in vitro DNA-binding data, presented in the next section, support model (a) and argue against model (b).
TP47 Tnp also presents an interesting case, in that it changes the OE/IE preference, but this change is manifested only in cis. When provided in cis, TP47 Tnp appears to favor IE utilization dramatically (257-fold higher than wt Tnp when using IE/IE, 54-fold higher than wt Tnp when using OE/IE, and only 11-fold higher than wt Tnp when using OE/OE). No such IE preference is observed when it is provided in trans. In trans, the frequencies of IE/IE, OE/IE and OE/OE transposition are all increased 11 to 17-fold. A model to explain this is proposed later.
In Table 2 , the transposition frequency of wt and mutant Tnp in cis is generally much greater than in trans, consistent with previous ®ndings reported by Johnson et al. (1982) and Isberg et al. (1982) .
In vitro OE/IE binding properties of Tnp mutants
To answer whether the changes in transposition frequency by these mutant Tnp proteins were, at least in part, correlated with changes in their binding af®nity to OE and IE sequences, we carried out an in vitro gel retardation assay. To measure the DNA-binding properties of the Tnp N-terminal mutants, we used derivatives of Tnp that contained a 108 amino acid residue truncation of the C terminus (Á369), which are transpositionally inactive. The C-terminal region of Tnp was shown to be involved in Tnp dimerization , which appears to inuence Tnp binding to OE (de la Cruz et al., 1993; . TnpÁ369 binds to OE as a monomer , so the abundance of Tnp-OE complexes is a simple re¯ection of the Tnp-OE af®nity, and is not complicated by the dimerization reaction. Moreover, protection assays and DNA-bending assays suggest that the full-length Tnp-OE complexes and TnpÁ369-OE complexes have similar properties despite differences in protein stoichiometry (Wiegand & Reznikoff, 1994; , 1997 .
We used pRZ9000 ; Figure 2 and Table 1 ) which encodes wt Tnp truncated after residue 369 (designated Á369). Mutations YH41, TP47, EK54 and EV54 were each subcloned into pRZ9000 to yield the truncated version of each mutant Tnp.
First, crude cell extracts containing wt, YH41, TP47, EK54 and EV54 TnpÁ369 were used in a gel-retardation assay with a labeled 53 bp DNA fragment containing the OE or a 56 bp DNA fragment containing the IE. The DNA containing the IE was prepared from a dam strain. An approximately equal amount of each TnpÁ369 was used, according to quanti®cation of crude extracts by densitometric scanning of Coomassie blue-stained SDS/polyacrylamide gels. The results are shown in Figure 3 . IE binding of TnpÁ369 is complicated by the presence of Fis protein in crude cell extracts, which also binds unmethylated IE (Weinreich & Reznikoff, 1992) and thus competes with TnpÁ369 for IE binding. Nevertheless, it is clear that YH41, TP47 and EV54 TnpÁ369 are all signi®cantly enhanced for both OE and IE binding, whereas EK54 TnpÁ369 is greatly enhanced for OE binding but only slightly enhanced for IE binding. In fact, in the gel shown (Figure 3(a) ), EK54 TnpÁ369 has shifted virtually all the labeled OE into the TnpÁ369-OE complex, thus the full extent of enhanced OE binding by EK54 TnpÁ369 is not reected in this gel. Note also that TP47 TnpÁ369 enhances IE binding more than it enhances OE binding.
In order to study OE and IE binding of TP47 and EK54 TnpÁ369 more accurately, we then puri®ed wt, TP47 and EK54 TnpÁ369. All three proteins were found to be overexpressed to a similar level and puri®ed to a similar yield and purity (% 85% pure), indicating that the three proteins have similar biochemical properties. Gel retardation assays were again carried out with ®xed Figure 3 . Gel retardation assays with crude extracts prepared from cells containing wt or mutant TnpÁ369. (a) OE binding; 2 nM 53 bp labeled DNA fragment containing OE was used in a binding reaction with crude cell extracts containing equivalent amount of wt or mutant TnpÁ369. (b) IE binding; same as OE binding except that the labeled DNA used was a 56 bp fragment containing IE, and that the amount of each TnpÁ369 used was ten times more than that in OE binding. The percentage of the total labeled DNA of each lane that is found in the OE-TnpÁ369 and the IE-TnpÁ369 complexes was determined with a Betascope (see Materials and Methods). IE is also bound by the Fis protein present in the crude extracts, and the IE-Fis complex nearly disappeared when the DNA containing IE was puri®ed from a dam strain (data not shown), consistent with results reported by Weinreich & Reznikoff (1992) .
concentrations ($0.4 nM) of the same labeled OE or IE fragments mentioned above and varying concentrations of each TnpÁ369 to determine a titration curve for each protein and DNA combination. Figure 4 (a) and (b) show an example of such a titration experiment with OE and IE, respectively. Figure 4 (c) and (d) show the corresponding titration curves for each TnpÁ369. All three proteins were puri®ed in parallel on two independent occasions. The gel retardation assay was performed at least twice with each group of puri®ed protein preparations. The relative positions and trends of the curves from each experiment are the same, although the absolute activity of the proteins varied (see the legend to Figure 4) .
The OE and IE binding experiments using puri®ed TnpÁ369 proteins demonstrated that the altered in vivo (trans) transposition properties of the mutants were a result of altered OE and IE binding af®nities. EK54 TnpÁ369 binds to OE better than wt TnpÁ369, but it binds to IE poorer than wt TnpÁ369. Wild-type and EK54 TnpÁ369 binding to OE has also been studied extensively by , 1997 with qualitatively the same results. TP47 TnpÁ369 enhances both OE and IE binding compared to wt TnpÁ369. Since the position of the``bound'' complex in these gel shift assays was already determined to correspond to TnpÁ369 monomer-OE or IE complexes , these results indicate that the increased or decreased in vivo transposition frequency of these mutants observed in the previous section correlates with their increased or decreased binding af®nity to the respective ends, and is un- Figure 4 . Gel retardation assays with puri®ed wt, EK54 and TP47 TnpÁ369. (a) and (b) Titration of 11 fmol (0.4 nM) of the labeled OE and IE DNA, respectively, with increasing amounts of the puri®ed TnpÁ369 preparations. The triangles above the lanes indicate the relative amount of puri®ed TnpÁ369 added in each reaction. The percentage of the total labeled DNA of each lane that is found in the OE-TnpÁ369 and the IE-TnpÁ369 complexes was determined with a Phosphorimager (Molecular Dynamics), and shown as OE and IE titration curves in (c) and (d), respectively. Each experiment was performed at least twice with each of the two groups of puri®ed protein preparations. Shown here are the data of one representative experiment, for OE and IE, respectively. The relative positions and trends of the curves from each experiment is the same, although the absolute activity of the proteins varied with (1) the method of the protein preparation (which group of protein preparation was used), and (2) the age of the protein preparation. This is why the results from different experiments were not averaged.
Tn5 Transposase DNA Binding Mutants likely to be due to an altered ability to interact with another protein factor involved in transposition. For EK54 TnpÁ369, the increased binding to OE and decreased binding to IE suggests that Lys54 either makes a more favorable interaction with one or more OE-speci®c base(s) than Glu54, but a less favorable interaction with the corresponding IE-speci®c base(s), and/or interacts more favorably with the OE DNA backbone, and less favorably with the IE DNA backbone, than Glu54. To strictly differentiate between these two possibilities, three-dimensional structural analysis will need to be performed. In subsequent work we shall investigate this question with more genetic and biochemical experiments.
We also puri®ed EV54 TnpÁ369 in one experiment and tested DNA binding in parallel with wt and EK54 TnpÁ369. We found that EV54 increased both OE and IE binding, but to a small extent (data not shown). This is consistent with the in vivo transposition data of EV54 Tnp.
Discussion
The N terminus of Tn5 Tnp was proposed from deletion and null point mutation studies to be important in Tnp binding to OE and IE sequences of Tn5 and IS50. Here, we tried a novel approach to search for the amino acid residues in the Tnp N terminus that may be in close contact with the OE/IE sequences in a Tnp-DNA complex. We sought Tnp mutants that enhanced OE/OEmediated transposition. We reasoned that a mutant Tnp with an enhanced recognition of the OE might do so by virtue of contacts with nucleotides that differ between OE and IE (OE and IE differ at seven out of 19 positions), and thus might manifest a change-of-speci®city compared to wt Tnp. Of the four mutants isolated with an enhanced OE/OE transposition phenotype, one mutant (EK54) has the desired change-of-speci®city phenotype. It increased OE/OE transposition, but decreased OE/ IE and IE/IE transposition. A second mutant (TP47) has a more complicated change-of-speci®city phenotype. It increased IE/IE and OE/IE transposition much more dramatically, as opposed to OE/OE transposition, but this effect is seen only in cis. When TP47 Tnp was provided in trans to the end sequences, transposition involving all end combinations was enhanced to a similar, more modest degree.
It was possible that the properties of the Tnp mutants could be explained by altered interactions with host factors. This was ruled out by performing gel shift assays using wt and the mutant forms of Tnp, with OE and IE DNA. These assays demonstrated that the four mutant Tnp have altered af®nities for OE and IE DNA, consistent with their in vivo phenotypes.
As far as we are aware, such a genetic/biochemical approach is unique in studying protein-DNA interactions. Sakai & Kleckner (1996) and N.
Tavakoli & K. Derbyshire (personal communication) have studied Tnp-end sequence interactions in Tn10 and Tn903, respectively, by isolating transposase mutants that suppressed defective mutant end sequences. Several interesting mutants were isolated; however, neither group has identi®ed a transposase mutant that is speci®cally altered in end sequence recognition. A possible reason for this lack of success is that the base-pairs in the end sequences responsible for speci®c binding by transposase may act cooperatively, such that single mutations of the ends may not be easily rescued by a single mutation in the transposase. Our approach is different and possibly more advantageous, since we started off with two functional end sequences, which differ at more than one base-pair. The results of our studies are discussed in more detail below.
EK54 TnpÁ369 in crude extracts greatly enhanced OE binding but only slightly enhanced IE binding, compared to wt TnpÁ369. When puri®ed, EK54 TnpÁ369 enhanced OE binding compared to wt TnpÁ369, while decreasing IE binding relative to wt. The reason for the different results obtained with crude extract and with puri®ed TnpÁ369 is not clear, but it may be due to an imprecise measurement of TnpÁ369 quantities in crude extracts, or the in¯uence of other factors present in the crude extracts. But the trend in the two experiments is the same, in that OE binding is much more preferred than IE binding when using EK54 compared to wt TnpÁ369. The results with puri®ed TnpÁ369 are also in good agreement with the in vivo transposition data, indicating that the EK54 phenotype observed in vivo is caused by its direct effect on DNA binding as observed in vitro (as opposed to an indirect effect through its interaction with another factor present in the cell).
A possible molecular explanation for the behavior of EK54 Tnp is suggested by the properties of EV54 Tnp. Since the side-chain of Val is unable to form a hydrogen bond with DNA (although it may interact with DNA through van der Waals interactions with its hydrophobic side-chain), the fact that EV54 binds better to OE and IE than wt indicates that Glu54 in wt Tnp does not make a favorable interaction with OE or IE, but rather, might be slightly inhibitory due to its negative charges. In view of that, Lys54 may be even more unfavorable in contacting IE due to its bulky side-chain, but may be able to make a favorable interaction(s) with OE by being a hydrogen bond donor (the Glu side-chain can act only as a hydrogen bond acceptor). If this is true, thymine is a good candidate base that only the Lys side-chain can contact, since it can only be a hydrogen bond acceptor.
TP47 TnpÁ369 in crude extracts as well as in puri®ed form signi®cantly enhanced both OE and IE binding. It seems to differentiate OE versus IE in a manner similar to wt TnpÁ369 in vitro, although with higher af®nities for both. Since the protein is added in trans to the DNA in these gel-retardation experiments, and since in vivo, TP47 Tnp differen-tiates OE versus IE similar to wt Tnp in trans, the in vitro DNA binding data agree well with the in vivo transposition data. To test in vitro DNAbinding in cis, we would have to develop a system to transcribe and translate Tnp derivatives in vitro from a DNA that also contains the end sequences. Even if this were done, the total binding observed would be the combined result of cis and trans binding, and there is no rigorous way of measuring the cis binding alone.
Nevertheless, TP47 is an unusual mutant for two reasons: (a) it manifests its IE preference only in cis, and (b) it increases transposition and DNAbinding through a Pro substitution for Thr. One possible model that can be used to explain (a) is that the conformational change introduced by Pro47 that makes the Tnp optimal for interaction with IE may be unstable; perhaps only newly translated Tnp takes on such a conformation (thus the cis preference). Soon afterwards, a conformational change happens that renders the TP47 Tnp only moderately elevated in its ability to interact with both OE and IE, compared to wt Tnp. Note that such a mechanism is invoked here to explain the excessive cis preference of the TP47 Tnp in combination with IE, and does not replace the previously proposed dimerization inactivation model (Weinreich et al., 1994) , which could explain the general cis preference of wt and other mutant Tnp proteins, including the cis preference of TP47 Tnp, when using two OEs.
Pro is generally thought to be a secondary structure breaker in proteins. The fact that TP47 enhances DNA-binding and transposition seems at ®rst glance very peculiar. A.S. Silbergleit, V.A. Lanzov and N. Benuch (personal communication) have identi®ed a possible helix-turn-helix motif in the Tnp N-terminal region, using a self-developed motif searching program that is similar to the neural network programs for protein secondary structure predictions (e.g. Rost & Sander, 1993) . This motif is: According to this model, Thr47 is the second residue from the N terminus of the second helix (the recognition helix in known HTH motifs). It is of interest that Richardson & Richardson (1988) reported that among 215 a-helices from 45 different globular proteins whose three-dimensional structures had been well de®ned, Pro was found to be preferred at (and only at) the N1 position (second residue) of an a-helix, and Thr was less preferred compared to Pro at this position. The relative frequency of Pro versus Thr at this position was 2.6:0.8, after being normalized by the relative abundance of the two amino acids. According to Richardson & Richardson (1988) , Pro in the ®rst turn of a helix ®ts well in terms of its own backbone conformation, and its rigid structure should have some stabilizing in¯uence. In addition, Pro in the ®rst turn should help block continuation of the helix in the NH 2 -terminal direction (Richardson & Richardson, 1988) . The TP47 substitution of Tnp may increase DNA-binding and transposition by stabilizing the a-helix in which it resides, and/or by slightly shifting the beginning position and/or orientation of the helix backbone. Richardson & Richardson (1988) also con®rmed previous studies (Ptitsyn, 1969; Shoemaker et al., 1987) that showed an asymmetrical preference for negatively charged side-chains in the ®rst turn and positively charged side-chains in the last turn of an a-helix. This may be due to stabilizing interactions of these charged side-chains with the helix dipole, and/or the formation of side-chain to main-chain hydrogen bonding. According to their statistical data, Lys was more preferred than Glu at the last position (the C-cap position) of an a-helix, and His was more preferred than Tyr at the position just before the C-cap (the C1 position). Using these observations, we propose that YH41 and EK54 may increase DNA binding and transposition by stabilizing the respective a-helices in which they reside, and/or by slightly altering the ending positions of the respective helices.
It is formally possible that the increase observed in the DNA-binding activity in the gel retardation assays may be due to an increased proportion of the population of puri®ed mutant Tnp molecules being generally active, rather than due speci®cally to an elevated DNA-binding activity. However, the fact that EK54 TnpÁ369 displays different effects in its binding activity to DNA containing OE and IE clearly demonstrates that for this mutant, it is the DNA-binding activity that is directly affected. The close proximity of the locations of the other three mutations to position 54 suggests that it is quite likely that they, too, directly affect the DNAbinding activity.
The fact that we were able to isolate hypertransposing Tnp mutants that bind DNA better than wt Tnp means that wt Tnp has a sub-optimal DNA-binding motif. This is likely to be the result of evolutionary selection, since optimal DNA-binding by Tnp (coupled with its nucleolytic activity causing DNA nicking and breaking) and subsequent high-level transposition causing frequent insertion mutations would be detrimental to the host cell, and therefore be disadvantageous to the transposable element itself. Indeed, many transposable elements seem to contain some form of down-regulation of their transposition frequency (Berg & Howe, 1989) . Tn5 transposition has been shown to be tightly controlled at multiple steps including tnp promoter activity, IE availability (both of which are regulated by host dam methylation), the abundance of the Inh protein, and a mechanism preventing translation of readthrough transcripts of tnp initiated from fortuitous promoters upstream (reviewed by Berg, 1989; Reznikoff, 1993) . Our results suggest that Tn5 transposition Tn5 Transposase DNA Binding Mutants is also down-regulated by an inef®cient Tnp-end sequence binding reaction.
It appears that wt Tnp evolved to recognize OE and IE at a subtly balanced frequency to give both Tn5 and IS50 transposition. Transposition of Tn5 propagates the antibiotic resistances that it carries, while transposition of IS50 presumably can lead to the evolution of new Tn5-like elements. This could be another explanation of why Pro47 or Lys54 was not found in wt Tnp.
Finally, the approach utilized in this study may be useful in other systems in which the same protein binds to different sites, for identifying speci®c contacts between the protein and its targets. Such a genetic and biochemical approach can often complement a structural approach, and provide independent insight into the interaction between a protein and DNA.
Materials and Methods
Media and reagents
Bacterial strains were grown in LB for DNA cloning and mating-out assays. SOC medium (Sambrook et al., 1989) was used for all electroporations. Tryptone-phosphate medium (Moore et al., 1993) was used for overexpression of TnpÁ369 and its mutant derivatives, both for preparing crude extracts and for protein puri®cation. Glucose minimal Miller medium (Miller, 1972) containing 0.3% (w/v) Casamino Acids, 40 mg/ml of 5-bromo-4-chloro-3-indolyl-b-D-galactoside, and 0.05% (w/v) phenyl-b-D-galactoside (referred to here as Trp À -XG-PG plates) was used for papillation assays. Antibiotics were purchased from Sigma and used in the following concentrations: ampicillin, 100 mg/ml; kanamycin, 40 mg/ml; tetracycline, 15 mg/ml; chloramphenicol, 20 mg/ml; nalidixic acid, 20 mg/ml; and gentamycin, 5 mg/ml. Restriction endonucleases were obtained from New England Biolabs and Promega Corp. Taq DNA polymerase (for PCR mutagenesis) and phage T4 DNA ligase were from Promega Corp. Sequenase 2.0 was from United States Biochemical Corp. AMV reverse transcriptase was from Molecular Genetic Resources. Calf intestinal alkaline phosphatase was from Boehringer Mannheim. All oligonucleotides were synthesized on an Applied Biosystems (Foster City, CA) model 391 DNA oligonucleotide synthesizer. Radioactive nucleotides were purchased from Amersham.
Bacterial strains and plasmids
All bacterial strains and plasmids used in this study are described in Table 1 . All strains were derivatives of Escherichia coli K-12, except for the B-strain BL21(DE3) pLysS. The structures of some of the plasmids are shown in Figure 2 . All cloning was done using strain DH5a. The results of all cloning and site-directed mutagenesis manipulations were con®rmed by DNA sequence analysis.
Plasmid pRZ5412 that encodes full-length Tnp was constructed as follows: the small NheI-BamHI fragment of pRZ3271-26G containing the part of the tnp gene encoding the C terminus of Tnp was substituted with the corresponding NheI-BamHI fragment from pRZ7055, resulting in the insertion of a kanamycin resistance gene between the end of the tnp gene and IE. The resulting plasmid is called pRZ5400. An A¯II restriction site was introduced just upstream of the tnp gene but within the IS50R sequence in pRZ5400 by site-directed-mutagenesis (Kunkel et al., 1987) , using the oligonucleotide sequence 5 H ACGTTACCATCTTAAGAGGTCACCT 3 H . The strain CJ236 was used to prepare the single-stranded phagemid DNA for the mutagenesis procedure. An EcoRI-HpaI fragment from the resulting plasmid containing the A¯II site was subcloned into the unmutagenized pRZ5400 to create pRZ5404. This ensured that no unintended mutation was introduced into the plasmid during the course of site-directed mutagenesis. Finally, pRZ5412 was constructed by substituting the small HpaI-NotI fragment of pRZ5404 with the corresponding fragment from pRZ7016, introducing the MA56 mutation, which changes the start codon AUG of the inh gene into GCC, thereby eliminating Inh synthesis (Wiegand & Reznikoff, 1992) . This unavoidably also changes the Met56 residue of Tnp into Ala56, which according to Wiegand & Reznikoff (1992) , does not greatly alter Tnp function.
pFMA187(OE/OE), which was one of the plasmids used in in vivo cis transposition assays, was constructed by substituting the IE sequence in pFMA187(OE/IE) with an OE-containing sequence via site-directed mutagenesis (Kunkel et al., 1987) . The oligonucleotide used in this mutagenesis was 5 H TATCATCGATAATACTTGTG-TATAAGAGTCAGGCGATTTGCAATTCCCCGGAT 3
H . Each of the tnp gene single mutations that resulted in YH41, TP47, EK54 and EV54, was then subcloned from their original pRZ5412 vector into each of the three versions of pFMA187: (OE/IE), (IE/IE) and (OE/OE), between the corresponding HpaI site and NotI site. Note that the MA56 mutation is present in all the original and derived plasmids in this series. pRZ5452, pRZ5453, and pRZ5454 were constructed by deleting the DNA between the two BspHI sites¯anking the tnp gene in pFMA187(OE/IE), (IE/IE) and (OE/OE), respectively, resulting in the complete loss of the tnp sequence, while maintaining the OE and IE sequences. pRZ9000 encodes the N-terminal 368 amino acid residues of Tnp followed by a glycine residue, under the control of the T7 promoter in a pET-21d() based vector. The tnp mutations YH41, TP47, EK54 and EV54 were each subcloned into pRZ9000 from their original pRZ5412 vector, between a HpaI site and a BsmI site in the tnp gene. Again, the MA56 mutation is present in all constructs.
PCR random mutagenesis
PCR reactions were carried out using two different reaction conditions: (a) similar to that described by Zhou et al. (1991) , including, in a 100 ml reaction volume, 10 mM Tris-HCl (pH9 at 25 C), 50 mM KCl, 0.1% (v/v) Triton X-100, 1.5 mM MgCl 2 , 50 mM of each dNTP, 2 to 3 fmol of template, 30 pmol of each primer, and ®ve units of Taq DNA polymerase. (b) Same as (a) except containing 200 mM of each dNTP, and 250 mM MnCl 2 . pRZ5412 (encoding the tnp gene) was used as template. The phage T7 primer (New England Biolabs, catalog no. 1248; which hybridizes upstream of the tnp gene), and the p801 primer (which corresponds to nucleotides 820 to 801 of the IS50R sequence) were used as the two primers to synthesize a PCR product of $880 bp in length. An A¯II-NotI fragment of this PCR product was substituted for the corresponding fragment of pRZ5412. The ligation product was electroporated into strain MDW320, and screened for transposition mutants by a papillation assay (see below). After isolation and puri®-cation of the mutants, the entire region between the A¯II and the NotI site in each of the mutants was sequenced.
Isolation of tnp mutants
The papillation assay (initially described by ) was used to screen for tnp mutants causing increased or decreased transposition frequency involving two OEs. In this assay, the frequency of transposition events is approximated by the accumulation of Lac papillae in an otherwise Lac À colony. The strain MDW320 contains a papillation factor pOXGen386, which is a modi®ed F factor containing two OEs in inverted orientation¯anking the lacZYA H genes and a tetracycline resistance gene. The lacZ gene lacks its transcriptional and translational initiation signals, thus the strain forms white colonies on Trp À -XG-PG plates. When pRZ5412 is electroporated into MDW320, the Tnp encoded by pRZ5412 causes occasional transposition of the sequence on pOXGen386¯anked by the two OEs. The events that fused the lacZ gene to an actively transcribed gene in the correct reading frame will manifest themselves as blue papillae on an otherwise white colony. The rate of appearance of these papillae is a measurement of the transposition frequency induced by the wt or mutant alleles of the tnp gene on pRZ5412.
We carried out the papillation assay similarly to that described by , except that our assay was performed in trans, the Trp À -XG-PG plates (with tetracycline and ampicillin) were used instead of lactose MacConkey plates for better sensitivity of papillae detection, and the plates were incubated at 32 C instead of 37 C, since we found that papillation is much more ef®cient at 32 C than at 37 C, 42 C or 28 C (data not shown).
Mating-out assay
The mating-out assay is performed essentially as described by Yin et al. (1988) . It is more quantitative than the papillation assay. It measures the movement of a transposable element from a plasmid to the F factor in the cell. After transfer of the F factor into recipient cells through conjugation, the total number of exconjugants is compared with the number of exconjugants that have received the transposon. The ratio of the two is a measurement of the transposition frequency.
In this study, the tnp gene is present either in cis (as in pFMA187OE/OE, OE/IE and IE/IE; Table 1 and Figure 2 ), or in trans (as in pRZ5412), of the DNA that contains the end sequences¯anking an antibiotic resistance marker (i.e. the transposable element whose movement is measured in this assay). In the trans situation, the ends are contained on pRZ5452, pRZ5453 or pRZ5454 (Table 1 ). The appropriate antibiotics were used to select for exconjugants that have or have not received the transposable element. The donor strain was JCM101/pOX38-Gen, which is a dam strain that contains the F factor derivative pOX38-Gen (Johnson & Reznikoff, 1984) . The recipient (F À ) strain was 14R525, which is a nalidixic acid resistant prototroph.
Preparation of crude cell extracts and transposase purification
Crude extracts were prepared from BL21(DE3) pLysS strain (Studier et al., 1990 ) essentially as described (Weinreich et al., 1994) except that cells were grown in tryptone-phosphate medium (Moore et al., 1993) containing chloramphenicol and ampicillin instead of LB, 0.1 mM IPTG was used for induction, and the sonicate was centrifuged for 15 instead of ®ve minutes at 4 C in a microfuge. The crude extracts were compared by SDS-PAGE. The Coomassie blue-stained gels were scanned by a densitometer. The wt and mutant TnpÁ369 band were compared, and an appropriate volume of each extract containing equivalent amount of the TnpÁ369 was used in the DNA-binding assay.
TnpÁ369 (wt and mutant) puri®cation was carried out once according to the procedures described by de la Cruz et al. (1993) and once with a modi®ed procedure. The previously described procedure includes induction with IPTG, harvesting, cell lysis with a French press, polyethylenimine (PEI) precipitation, 47% saturation (NH) 2 SO 4 precipitation, dialysis to remove (NH) 2 SO 4 , and heparin-agarose column chromotography. In our modi®ed protocol, precipitation with PEI was omitted because we observed that the majority of the overexpressed TnpÁ369 was lost at this step, rendering the protein we intended to purify a minor species in the supernatant after precipitation. We also did a 40% saturation (NH) 2 SO 4 precipitation instead of 47%, since we found that 40% is more effective in purifying TnpÁ369 against other proteins, compared to higher concentrations. Finally, we used a high-af®nity heparin-agarose matrix (Sigma catalog no. H0402, made by end-point attachment of heparin on 4% beaded agarose) that allowed TnpÁ369 to be recovered more ef®ciently. The equilibration and elution buffers used for the column contained 10% instead of 20% (v/v) glycerol described by de la Cruz et al. (1993) .
The concentration of EK54 TnpÁ369 was calculated by using the Bradford (1976) assay to determine total protein concentration and densitometric scanning of a Coomassie-stained SDS-PAGE gel to determine the percentage of EK54 TnpÁ369 in the sample. The concentrations of other puri®ed wt and mutant TnpÁ369 proteins were determined relative to EK54 TnpÁ369 in the same SDS gels. Each of the TnpÁ369 derivatives was % 85% pure.
Gel shift assay
This was performed essentially as described (Wiegand & Reznikoff, 1992) . For crude extract binding, about 2 ng (55 fmol) of a 32 P-labeled 53 bp DNA fragment containing the OE isolated from dam cells, or a 56 bp DNA fragment containing the IE isolated from dam cells was incubated with crude cell extracts containing equivalent amounts of wt or mutant TnpÁ369 in a 24 ml reaction volume in a buffer containing 20 mM sodium phosphate (pH7.5), 100 mM potassium glutamate, 1 mM DTT, 0.5 mM EDTA, 0.1% Triton X-100, 200 mg/ml bovine serum albumin, 10 mg/ml unlabeled calf thymus DNA as non-speci®c competitor. After incubation at 30 C for 30 minutes, 6 ml of a loading solution containing 20% glycerol and 0.05% (w/v) xylene cyanol was added before loading 25 ml of each reaction onto a 1.2 mm thick, 20 cm long, 8% (39:1, w/w acrylamide to bis-acrylamide) polyacrylamide gel. Electrophoresis was carried out at 4 C and 17 V/cm for three hours in a running buffer that contained 45 mM Tris-borate, 1.25 mM EDTA. Gels were dried, quanti®ed with a Betascope 603 blot analyzer (Betagen Corporation, Waltham, MA), and exposed to X-ray ®lm overnight.
Tn5 Transposase DNA Binding Mutants
For puri®ed TnpÁ369 binding, about 0.4 ng (11 fmol, ®nal concentration 0.4 nM) of the same labeled DNA as above was incubated with various amounts of puri®ed wt or mutant TnpÁ369 in a 27 ml reaction volume and same buffer composition as described above except with a tenfold higher concentration of unlabeled calf thymus DNA (100 mg/ml). Using 2 ng of the labeled DNA (as was done for the crude extract binding) yielded equivalent results (data not shown). After the incubation at 30 C for 30 minutes, 3 ml of a loading solution (50% glycerol, 0.02% xylene cyanol) was added, and subsequent steps were performed exactly as described above. Data were quanti®ed with a Phosphorimager (Molecular Dynamics).
